世界の血栓症・止血バイオマーカー市場は、2023年に約53億1,000万米ドルと評価され、2024年から2032年の予測期間にわたって5.9%を超える健全な成長率で成長すると予想されています。
血栓症・止血バイオマーカーは、フォン・ヴィレブランド因子（vWF）、フィブリノーゲン、D ダイマーなどの止血システムの成分から得られる検査パラメータです。これらのバイオマーカーは、特定の疾患またはその病態生理学的影響を検出するのに役立ち、臨床診療においてさまざまな用途があります。静脈血栓塞栓症（VTE）やその他の疾患のリスク推定と診断、リンパ腫患者の血栓性イベントの予測、膵臓がん患者の化学療法への反応、患者管理の強化など、大きなメリットがあります。
血栓症・止血バイオマーカー市場の成長は、静脈血栓塞栓症（VTE）のリスク増加に大きく起因しています。VTEのリスクは、心血管疾患、脳血管疾患、悪性疾患などのさまざまな臨床状態に関連しています。さらに、リスクは重傷または軽傷や肥満によって増加します。たとえば、2023年11月の米国心臓協会によると、肥満の人はVTEのリスクが高く、体重が増えるほどリスクが高くなります。Dダイマー、フィブリノーゲン、第VIII因子などのバイオマーカーは、VTEのリスクを予測し、治療への反応を監視するために使用されます。これにより、バイオマーカー製品の採用が大幅に促進され、予測期間中に市場の成長が促進されると予想されます。さらに、研究イニシアチブと資金の増加、および臨床診療におけるバイオマーカーの採用の増加は、予測期間にわたってさまざまな有利な機会をもたらします。しかし、バイオマーカーの使用に関連する高コスト、厳しい規制、および制限は、2024年から2032年の予測期間全体にわたって市場の成長に課題をもたらしています。
血栓症・止血バイオマーカーの世界市場調査において考慮した主要地域は、アジア太平洋地域、北アメリカ、ヨーロッパ、ラテンアメリカ、その他世界のその他の地域です。北アメリカは、血栓症・止血バイオマーカーの世界市場において、収益面で優位な地域です。この地域の市場成長は、高度に発達したヘルスケアインフラの存在、研究開発への多額の投資、高度な診断技術の普及などの要因によるものです。米国は、心血管疾患や血液疾患の有病率が高いことに加え、革新的な診断ソリューションを開発するために学術機関と業界各社が強力な協力関係を築いていることから、市場をリードしています。一方、アジア太平洋市場は、医療費の増加、血栓性疾患の有病率の増加、早期診断・治療の重要性に対する意識の高まりなどを背景に、予測期間中に最も速い速度で成長すると予測されています。中国、インド、日本などの国々では、生活習慣病による負担の増加、医療へのアクセスが改善された中間層の拡大、医療の質とアクセスの向上を目指した政府の取り組みなどにより、市場が大きく拡大しています。
目次
Table of Contents
Chapter 1. Global Thrombosis and Hemostasis Biomarkers Market Executive Summary
1.1. Global Thrombosis and Hemostasis Biomarkers Market Size & Forecast (2022-2032)
1.2. Regional Summary
1.3. Segmental Summary
1.3.1. By Product Type
1.3.2. By Application
1.3.3. By End-user
1.4. Key Trends
1.5. Recession Impact
1.6. Analyst Recommendation & Conclusion
Chapter 2. Global Thrombosis and Hemostasis Biomarkers Market Definition and Research Assumptions
2.1. Research Objective
2.2. Market Definition
2.3. Research Assumptions
2.3.1. Inclusion & Exclusion
2.3.2. Limitations
2.3.3. Supply Side Analysis
2.3.3.1. Availability
2.3.3.2. Infrastructure
2.3.3.3. Regulatory Environment
2.3.3.4. Market Competition
2.3.3.5. Economic Viability (Consumer's Perspective)
2.3.4. Demand Side Analysis
2.3.4.1. Regulatory frameworks
2.3.4.2. Technological Advancements
2.3.4.3. Environmental Considerations
2.3.4.4. Consumer Awareness & Acceptance
2.4. Estimation Methodology
2.5. Years Considered for the Study
2.6. Currency Conversion Rates
Chapter 3. Global Thrombosis and Hemostasis Biomarkers Market Dynamics
3.1. Market Drivers
3.1.1. Rising Prevalence of Venous Thromboembolism (VTE)
3.1.2. Advances in Cancer Diagnosis and Treatment
3.2. Market Challenges
3.2.1. High Cost and Stringent Regulations
3.2.2. Limitations Associated with Biomarker Use
3.3. Market Opportunities
3.3.1. Growing Research Initiatives and Funding
3.3.2. Increasing Adoption of Biomarkers in Clinical Practice
Chapter 4. Global Thrombosis and Hemostasis Biomarkers Market Industry Analysis
4.1. Porter's 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter's 5 Force Model
4.1.7. Porter's 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Thrombosis and Hemostasis Biomarkers Market Size & Forecasts by Product Type 2022-2032
5.1. Segment Dashboard
5.2. Global Thrombosis and Hemostasis Biomarkers Market: Product Type Revenue Trend Analysis, 2022 & 2032 (USD Billion)
5.2.1. Instruments
5.2.2. Reagents & Consumables
Chapter 6. Global Thrombosis and Hemostasis Biomarkers Market Size & Forecasts by Application 2022-2032
6.1. Segment Dashboard
6.2. Global Thrombosis and Hemostasis Biomarkers Market: Application Revenue Trend Analysis, 2022 & 2032 (USD Billion)
6.2.1. Deep Vein Thrombosis (DVT)
6.2.2. Pulmonary Embolism (PE)
6.2.3. Disseminated Intravascular Coagulation (DIC)
6.2.4. Others
Chapter 7. Global Thrombosis and Hemostasis Biomarkers Market Size & Forecasts by End-user 2022-2032
7.1. Segment Dashboard
7.2. Global Thrombosis and Hemostasis Biomarkers Market: End-user Revenue Trend Analysis, 2022 & 2032 (USD Billion)
7.2.1. Hospitals & Clinics
7.2.2. Diagnostic Laboratories
7.2.3. Others
Chapter 8. Global Thrombosis and Hemostasis Biomarkers Market Size & Forecasts by Region 2022-2032
8.1. North America Thrombosis and Hemostasis Biomarkers Market
8.1.1. U.S. Thrombosis and Hemostasis Biomarkers Market
8.1.1.1. Product Type breakdown size & forecasts, 2022-2032
8.1.1.2. Application breakdown size & forecasts, 2022-2032
8.1.1.3. End-user breakdown size & forecasts, 2022-2032
8.1.2. Canada Thrombosis and Hemostasis Biomarkers Market
8.2. Europe Thrombosis and Hemostasis Biomarkers Market
8.2.1. U.K. Thrombosis and Hemostasis Biomarkers Market
8.2.2. Germany Thrombosis and Hemostasis Biomarkers Market
8.2.3. France Thrombosis and Hemostasis Biomarkers Market
8.2.4. Spain Thrombosis and Hemostasis Biomarkers Market
8.2.5. Italy Thrombosis and Hemostasis Biomarkers Market
8.2.6. Rest of Europe Thrombosis and Hemostasis Biomarkers Market
8.3. Asia-Pacific Thrombosis and Hemostasis Biomarkers Market
8.3.1. China Thrombosis and Hemostasis Biomarkers Market
8.3.2. India Thrombosis and Hemostasis Biomarkers Market
8.3.3. Japan Thrombosis and Hemostasis Biomarkers Market
8.3.4. Australia Thrombosis and Hemostasis Biomarkers Market
8.3.5. South Korea Thrombosis and Hemostasis Biomarkers Market
8.3.6. Rest of Asia Pacific Thrombosis and Hemostasis Biomarkers Market
8.4. Latin America Thrombosis and Hemostasis Biomarkers Market
8.4.1. Brazil Thrombosis and Hemostasis Biomarkers Market
8.4.2. Mexico Thrombosis and Hemostasis Biomarkers Market
8.4.3. Rest of Latin America Thrombosis and Hemostasis Biomarkers Market
8.5. Middle East & Africa Thrombosis and Hemostasis Biomarkers Market
8.5.1. Saudi Arabia Thrombosis and Hemostasis Biomarkers Market
8.5.2. South Africa Thrombosis and Hemostasis Biomarkers Market
8.5.3. Rest of Middle East & Africa Thrombosis and Hemostasis Biomarkers Market
Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. F. Hoffmann-La Roche Ltd
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Market Strategies
9.3.2. BioMedica Diagnostics
9.3.3. Siemens Healthcare Private Limited
9.3.4. Abbott
9.3.5. HORIBA Medical
9.3.6. BIOMERIEUX
9.3.7. QuidelOrtho Corporation
9.3.8. Stago Group
9.3.9. Thermo Fisher Scientific Inc.
9.3.10. Bio-Rad Laboratories, Inc.
9.3.11. Beckman Coulter, Inc.
9.3.12. Sysmex Corporation
9.3.13. Enzo Biochem, Inc.
9.3.14. Diazyme Laboratories, Inc.
9.3.15. Agilent Technologies, Inc.
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
List of Tables
TABLE 1. Global Thrombosis and Hemostasis Biomarkers Market, Report Scope
TABLE 2. Global Thrombosis and Hemostasis Biomarkers Market Estimates & Forecasts by Region 2022-2032 (USD Billion)
TABLE 3. Global Thrombosis and Hemostasis Biomarkers Market Estimates & Forecasts by Product Type 2022-2032 (USD Billion)
TABLE 4. Global Thrombosis and Hemostasis Biomarkers Market Estimates & Forecasts by Application 2022-2032 (USD Billion)
TABLE 5. Global Thrombosis and Hemostasis Biomarkers Market Estimates & Forecasts by End-user 2022-2032 (USD Billion)
TABLE 6. Global Thrombosis and Hemostasis Biomarkers Market by Region, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 7. Global Thrombosis and Hemostasis Biomarkers Market by Segment, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 8. Global Thrombosis and Hemostasis Biomarkers Market by Region, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 9. Global Thrombosis and Hemostasis Biomarkers Market by Segment, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 10. Global Thrombosis and Hemostasis Biomarkers Market by Region, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 11. Global Thrombosis and Hemostasis Biomarkers Market by Segment, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 12. Global Thrombosis and Hemostasis Biomarkers Market by Region, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 13. Global Thrombosis and Hemostasis Biomarkers Market by Segment, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 14. Global Thrombosis and Hemostasis Biomarkers Market by Region, Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 15. U.S. Thrombosis and Hemostasis Biomarkers Market Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 16. U.S. Thrombosis and Hemostasis Biomarkers Market Estimates & Forecasts by Segment 2022-2032 (USD Billion)
TABLE 17. U.S. Thrombosis and Hemostasis Biomarkers Market Estimates & Forecasts by Segment 2022-2032 (USD Billion)
TABLE 18. Canada Thrombosis and Hemostasis Biomarkers Market Estimates & Forecasts, 2022-2032 (USD Billion)
TABLE 19. Canada Thrombosis and Hemostasis Biomarkers Market Estimates & Forecasts by Segment 2022-2032 (USD Billion)
TABLE 20. Canada Thrombosis and Hemostasis Biomarkers Market Estimates & Forecasts by Segment 2022-2032 (USD Billion)
…..
This list is not complete, final report does contain more than 100 tables. The list may be updated in the final deliverable.
List of Figures
FIG 1. Global Thrombosis and Hemostasis Biomarkers Market, Research Methodology
FIG 2. Global Thrombosis and Hemostasis Biomarkers Market, Market Estimation Techniques
FIG 3. Global Market Size Estimates & Forecast Methods
FIG 4. Global Thrombosis and Hemostasis Biomarkers Market, Key Trends 2023
FIG 5. Global Thrombosis and Hemostasis Biomarkers Market, Growth Prospects 2022-2032
FIG 6. Global Thrombosis and Hemostasis Biomarkers Market, Porters 5 Force Model
FIG 7. Global Thrombosis and Hemostasis Biomarkers Market, PESTEL Analysis
FIG 8. Global Thrombosis and Hemostasis Biomarkers Market, Value Chain Analysis
FIG 9. Global Thrombosis and Hemostasis Biomarkers Market by Segment, 2022 & 2032 (USD Billion)
FIG 10. Global Thrombosis and Hemostasis Biomarkers Market by Segment, 2022 & 2032 (USD Billion)
FIG 11. Global Thrombosis and Hemostasis Biomarkers Market by Segment, 2022 & 2032 (USD Billion)
FIG 12. Global Thrombosis and Hemostasis Biomarkers Market by Segment, 2022 & 2032 (USD Billion)
FIG 13. Global Thrombosis and Hemostasis Biomarkers Market by Segment, 2022 & 2032 (USD Billion)
FIG 14. Global Thrombosis and Hemostasis Biomarkers Market, Regional Snapshot 2022 & 2032
FIG 15. North America Thrombosis and Hemostasis Biomarkers Market 2022 & 2032 (USD Billion)
FIG 16. Europe Thrombosis and Hemostasis Biomarkers Market 2022 & 2032 (USD Billion)
FIG 17. Asia Pacific Thrombosis and Hemostasis Biomarkers Market 2022 & 2032 (USD Billion)
FIG 18. Latin America Thrombosis and Hemostasis Biomarkers Market 2022 & 2032 (USD Billion)
FIG 19. Middle East & Africa Thrombosis and Hemostasis Biomarkers Market 2022 & 2032 (USD Billion)
FIG 20. Global Thrombosis and Hemostasis Biomarkers Market, Company Market Share Analysis (2023)
…..
This list is not complete, final report does contain more than 50 figures. The list may be updated in the final deliverable.
